Delivery Order SPE2DR25D2014-SPE2DR26FA8N7

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 11, 2026, for 500 tablets of CellCept 500 mg, with a ceiling value of $13,137.60, under firm fixed-price pricing and no set-aside. Place of performance is Conshohocken, PA. The order's ultimate completion date is March 12, 2026. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs through the Defense Logistics Agency.

<p>The Defense Logistics Agency issued a $24,389.78 delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for CellCept 500 mg tablets (100 count), with an ultimate completion date of February 11, 2026.</p> <p>Place of performance is Conshohocken, PA. The order was awarded on a firm fixed-price basis with no set-aside.</p>

<p>The Defense Logistics Agency issued a $6,992.17 delivery order to AmerisourceBergen Drug Corp on February 23, 2026, for CellCept 500 mg tablets (100-count units), with final delivery due February 24, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price and carries no set-aside designation.</p>

The Defense Logistics Agency issued a $36,168.72 delivery order to AmerisourceBergen Drug Corp on February 17, 2026, for CellCept 500 mg tablets (100-count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical commodities to military healthcare programs worldwide. Place of performance is Conshohocken, PA. The ultimate completion date is February 18,...

The Defense Logistics Agency issued a $8,886.62 delivery order to Amerisourcebergen Drug Corp on February 27, 2026, for CellCept 500 mg tablets (100-count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate...

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 10, 2026, for CellCept 500 mg tablets (100 count) with a ceiling value of $23,193.72 under firm fixed-price terms.</p> <p>Place of performance is Conshohocken, PA. The order was completed on March 11, 2026. No set-aside was used.</p>

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 10, 2026, for 100 tablets of CellCept 500 mg, with a ceiling value of $5,335.99. The order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical commodities to support military healthcare programs worldwide. Place of performance is Conshohocken, PA. The order carries firm...

The Defense Logistics Agency awarded a $3,611.49 delivery order to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (100-count) under a firm fixed-price contract. The award was issued on September 15, 2025, with an ultimate completion date of September 16, 2025, and represents a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 11, 2026, for CellCept 250 mg capsules (100-count units) with a ceiling value of $4,941.69 under firm fixed pricing.</p> <p>Place of performance is Conshohocken, PA. The order completes on March 12, 2026. No set-aside was used.</p>

The Defense Logistics Agency awarded a delivery order valued at $31,318.38 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) under a firm fixed price contract. The award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical...